Cytodyn Inc (CYDY)

[LOL83001]

Ok Correction. BLA is the only thing I want to see right now in terms of drug development progress. Its a major milestone and it is CYDY's stated first priority per the annual report. Obviously as an investor, anything that moves the needle would be welcomed- BO, merger, partnership, breakthrough results in any indication. As a human, I want to see this drug safely to market and BLA is next major step in process to broadest use.

Product Available. I believe the $60M "on hand" value is old as it was figured at $120k /pp at 325mg dosage. In last presentation #'s are: $35k/pp and either 525 or 700mg thus it's more like $8.6-11.5M ( which treats 250 or 332 patients for 1 yr.) . And Annual Report under "Pre-Launch Inventory" states : "As of May 31, 2019 and May 1, 2018 the company did not have pre-launch inventory that qualified for capitalization pursuant to U.S. GAAP ASC 330 Inventory.". My understanding is once we get approval, it's cap. Does prognostic kit approval count?